Anti-Microbial Savior BioteQ , Ltd Current Cash

Anti-Microbial Savior BioteQ , Ltd (6864.TWO) currently reports a current cash of $400M as of June 2026. That compares with $150M in the prior-year period — up 173.0% year over year. Use the charts on this page to explore Anti-Microbial Savior BioteQ , Ltd's current cash history and peer comparisons.

Anti-Microbial Savior BioteQ , Ltd's current cash increased from $150M to $400M — a 173.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anti-Microbial Savior BioteQ , Ltd reported $400M in current cash as of June 2026. That compares with $150M in the prior-year period — up 173.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $400M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anti-Microbial Savior BioteQ , Ltd, and consider following 6864.TWO for alerts when major investors trade the stock.

Anti-Microbial Savior BioteQ , Ltd is classified in the Healthcare sector. On current cash, it currently shows $400M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6864.TWO with unrelated industries.